Study Stopped
No patients enrolled
Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer
Correlation of SNP Patterns With Fine Needle Aspiration Cytomorphology in High Risk Postmenopausal Women
1 other identifier
observational
N/A
1 country
1
Brief Summary
A study to examine the potential associations between common single nucleotide polymorphisms and pre-cancerous conditions in breast tissue specimens from postmenopausal women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started May 2005
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2005
CompletedFirst Submitted
Initial submission to the registry
May 19, 2006
CompletedFirst Posted
Study publicly available on registry
May 24, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 12, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
November 12, 2015
CompletedOctober 10, 2019
October 1, 2019
10.5 years
May 19, 2006
October 7, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlation of SNP patterns with cytlomorphology of breast fine needle aspirates.
develoment of algorithm for prediction of risk of developing breast cancer.
ongoing
Study Arms (1)
1
Post-menopausal women who are at increased risk for development of breast cancer on the basis of family or personal history.
Interventions
Eligibility Criteria
Post menopausal women, on or off hormone replacement therapy, at high risk of developing breast cancer
You may qualify if:
- postmenopausal women on or off hormone replacement therapy
- at high risk of developing breast cancer determined by family or personal history
- postmenopausal women not on hormone replacement therapy for at minimum six months prior to corresponding aspiration
- willing to participate in companion protocol (KUMC HSC#4601) for random periareolar fine needle aspiration (RPFNA) for correlational studies
You may not qualify if:
- women who have been on raloxifene, tamoxifen, letrozole, anastrozole or exemestane within the six months prior to RPFNA.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Carol Fabian, MDlead
- Intergenetics, Inc.collaborator
Study Sites (1)
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
Biospecimen
Fine needle aspirate
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carol J Fabian, MD
University of Kansas Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor, Director Breast Cancer Prevention Unit
Study Record Dates
First Submitted
May 19, 2006
First Posted
May 24, 2006
Study Start
May 1, 2005
Primary Completion
November 12, 2015
Study Completion
November 12, 2015
Last Updated
October 10, 2019
Record last verified: 2019-10
Data Sharing
- IPD Sharing
- Will not share
Global results will be published.